Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Truist Securities Maintains Buy on Vericel, Raises Price Target to $54

Author: Benzinga Newsdesk | March 01, 2024 09:44am
Truist Securities analyst Samuel Brodovsky maintains Vericel (NASDAQ:VCEL) with a Buy and raises the price target from $51 to $54.

Posted In: VCEL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist